Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03108950
Other study ID # F160404004
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2017
Est. completion date May 31, 2019

Study information

Verified date August 2019
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific aim of the study in our example is to conduct a feasibility translational home-based exercise trial established in the LEADERS (R2) project with the TExt-ME tele-exercise training system for participants with neurologic disability. We hypothesize that participants in this home-based tele-exercise training program will achieve similar gains in health and function outcomes as the onsite exercise training program. Further, there will be no difference in adverse side effects (safety) between the home-based and onsite exercise treatment groups.


Description:

TExT-ME is a home-based tele-exercise study providing a novel exercise program to participants with neurologic disabilities. The exercise curriculum is a Movement 2 Music (M2M) program developed during phase 2 of the grant (clinicaltrials.gov identifier NCT02533882). The exercise exercise classes are taught by trained dance instructors and are composed of a set of exercises tailored to the specific needs and capabilities of adults with neurologic disability. Each set of exercises is performed to high and low tempo music based on the individual's baseline level of function, with adjustments made to increase or decrease intensity if needed. The class consists of several training components: a) warmup (10 min.) to increase range of motion; strength/balance (15-20 min), aerobics (25-30 min. with rest periods as necessary); cool down (5 min).

The TExT-ME training and monitoring system is a user-centered design (UCD) involving a tele-exercise coach (e.g., a trained research staff person) interacting remotely with a participant in their home using video conferencing programs. Participants wear monitors to maintain safe levels of exercise and provide feedback regarding exercise intensity to the instructors. Self-reported indicators of exercise intensity are also collected using rating of perceived exertion.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date May 31, 2019
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Diagnosed with stroke

- MS - mild to moderate disability (Patient Determined Disease Steps Score 0-6)

- Able to use arms or arm/legs for exercise

- Ambulatory or use manual wheelchair

Exclusion Criteria:

- Cognitive impairment (Mini-Mental State Exam score < 24)

- Recent weight change (+/- 25 pounds in 1 year)

- Poorly controlled blood pressure

- Cardiovascular disease event within the past six months

- Severe pulmonary disease

- Renal failure

- Current tobacco user or quit within the last six months

- Current use of medications for psychosis

- Active pressure ulcers

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Movement to Music
The Movement to Music classes are composed of a set of exercises tailored to the specific needs and capabilities of each target group. The class will consist of and aerobic component and a strength component performed to varying music tempos. All movements will be choreographed by qualified dance instructors. Intervention is delivered using video-conferencing to connect the participant to their instructor.

Locations

Country Name City State
United States Lakeshore Foundation Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham Lakeshore Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiorespiratory Fitness as measured by sub-maximal VO2 Submax VO2 is assessed by the six minute walk test or the six minute push test. Participants wear a portable metabolic cart while walking or pushing 12 weeks
Primary Pain as measured by PROMIS Pain Interference Short Form 8a PROMIS Pain Interference Short Form 8a Questionnaire 12 weeks
Primary Fatigue as measured by PROMIS Fatigue Short Form 8a PROMIS Fatigue Short Form 8a Questionnaire 12 weeks
Primary Grip Strength as measured by hand grip dynamometer Participants exert as much force as possible using a Jamar hand grip dynamometer 12 weeks
Primary Strength as measured by Biodex System 3 Multijoint dynamometer Upper body strength is measured using a closed chain push/pull protocol. Lower body strength is measured using the knee flexion/extension protocol. 12 weeks
Primary Balance as measured by the Timed Up and Go The Timed to Up and Go test is performed using a chair with arms. The participants stand up from the chair, walk to a mark measured three meters from the chair then return back to the seat. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling. 12 weeks
Primary Balance as measured by Biodex Limits of Stability The Limits of Stability test is performed on the Biodex SD balance machine using the limits of stability protocol created by Biodex. 12 weeks
Primary Balance as measured by Repeated Chair Stands The repeated chair stands test is performed by asking participants to stand up and sit down 5 times as fast as possible. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling. 12 weeks
Primary Walking velocity as measured by the GaitRite 20 meter walk is completed on the GaitRite mat 12 weeks
Secondary Health Biomarkers as measured by blood analysis (insulin) Participants undergo a fasted blood draw to assess insulin 12 weeks
Secondary Health Biomarkers as measured by blood analysis (lipids) Participants undergo a fasted blood draw to assess lipids 12 weeks
Secondary Health Biomarkers as measured by blood analysis (fasting glucose) Participants undergo a fasted blood draw to assess glucose 12 weeks
Secondary Anthropometric measurements (BMI) height and weight are assessed to compute BMI 12 weeks
Secondary Circumference measurements to be reported as composite ratios (waist circumference, hip circumference, neck circumference) circumference measures are completed at the neck, hip, and waist. Waist to hip ratios are computed (A/G ratio) 12 weeks
Secondary Physical Function with Mobility Aid as measured by PROMIS Physical Function with Mobility Aid 455b PROMIS Physical Function with Mobility Aid 455b questionnaire 12 weeks
Secondary Anxiety as measured by PROMIS Emotional Distress-Anxiety Short Form 8a PROMIS Emotional Distress-Anxiety Short Form 8a questionnaire 12 weeks
Secondary Depression as measured by PROMIS Emotional Distress-Depression Short Form 8a PROMIS Emotional Distress-Depression Short Form 8a questionnaire 12 weeks
Secondary Sleep Disturbance as measured by PROMIS Sleep Disturbance Short Form 8a PROMIS Sleep Disturbance Short Form 8a questionnaire 12 weeks
Secondary Ability to participate in social roles and activities as measured by PROMIS Ability to Participate in Social Roles and Activities Short Form 8a PROMIS Ability to Participate in Social Roles and Activities Short Form 8a questionnaire 12 weeks
Secondary Nutrition Self-Efficacy as measured by the Nutrition Self-Efficacy Scale Nutrition Self-Efficacy Scale 12 weeks
Secondary Physical Exercise Self-Efficacy as measured by the Physical Exercise Self Efficacy Scale Physical Exercise Self Efficacy Scale 12 weeks
Secondary Pain intensity is measured by the PROMIS Pain Intensity Short Form PROMIS Pain Intensity Short Form questionnaire 12 weeks
Secondary Body Composition as measured using a DEXA scan GE Lunar Dual X-ray Absorptiometry is used to assess total body composition 12 weeks
Secondary Loneliness as measured by the Three-item loneliness scale Three item loneliness scale 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Suspended NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Enrolling by invitation NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05621980 - Finger Movement Training After Stroke N/A